Advertisement

Topics

Latest "Sinclair Pharma" News Stories

04:08 EDT 19th July 2018 | BioPortfolio

Here are the most relevant search results for "Sinclair Pharma" found in our extensive news archives from over 250 global news sources.

More Information about Sinclair Pharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sinclair Pharma for you to read. Along with our medical data and news we also list Sinclair Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sinclair Pharma Companies for you to search.

Showing "Sinclair Pharma" News Articles 1–25 of 6,600+

Relevant

CR Pharma to Acquire Jiangzhong Pharma for $667 Million

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent company, Jiangzhong Group, for $613 million, which will, when added to its current holdings, give CR Pharma majority control of Jiangzhong Group. Jiangzhong Group, the parent, owns a 43% stake in Jiang...


#jobs #lifescience Accountant – Biotech / Pharma (Up to $70K)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded Bio-Tech/Pharma Company is looking for a talented Staff Accountant to join their corporate headquarters located just west … Continue reading → Cet article #jobs #lifescience Accountant ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004. They discuss: • the drug assets acquired from companies including Xenova, IDEA and Inspire • Celtic Pharma’s Funds, their investors and their aims to raise US$750 M • attracting Big Pharma, ...


Verona Pharma plc: Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Verona Pharma plc: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO -- (Marketwired) -- 03/19/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the completion of the previously announced acq...

Verona Pharma plc: Verona Pharma Provides Clinical Development Update

Accelerates top-line data readouts from ongoing clinical trials with RPL554 in COPD and CFLONDON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a cli...

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

Probably Relevant

#jobs #lifescience In House Counsel (Biotech/Pharma)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: In House Counsel (Biotech/Pharma) .NY-new york, In House Counsel (Biotech/Pharma) $250-300K + Bonus and Equity Prestigious Startup Biotech/Pharmaceutical conglomerate (division of billion dollar entity) seeks In House Counsel … Continue reading → Cet article #jobs ...

Dow Pharma Solutions showcases pharma portfolio at CPhI NA

Dow Pharma Solutions – a division of the DowDuPont Specialty Products Division – will showcase its portfolio of pharma solutions at CPhI North America, taking place this week in Philadelphia

Pfenex, NT Pharma ink development & license pact for Pfenex's PF708 therapeutic equivalent candidate to Forteo

Pfenex Inc. and China NT Pharma Group Company Limited (NT Pharma) announced an agreement under which Pfenex granted NT Pharma non─exclusive development and exclusive commercialization rights to PF708

Verona Pharma plc: Block Listing Update

LONDON, May 31, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovativ...

#jobs #lifescience Pharma/Biotech Validation Specialist IV

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pharma/Biotech Validation Specialist IV .MA-Marlborough, We are seeking a candidate for a high priority role within a highly visible project for a global industry leader located in MA. … Continue reading → Cet article #jobs #lifescience Pharma/Biotech Validation Sp...

LEO Pharma sells major product portfolio to Karo Pharma for €260m

LEO Pharma has sold product portfolio of 10 products to Swedish company Karo Pharma for €260m.

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, they discuss: • Strategy after merger and key focus areas • Michael Yeomans' role at Bayer Schering Pharma • Biggest growth in speciality pharma areas • Clinical stage deals vs research stage co...

FSD Pharma (CSE: $HUGE.C) secures exclusive rights in Canada for line of proprietary products and premium access to #cannabinoid science research platform in Israel

TORONTO - June 6, 2018 (Investorideas.com Newswire) FSD Pharma Inc. (the "Company") (CSE: HUGE), is pleased to announce that its wholly - owned subsidiary FV Pharma Inc ("FV Pharma") have entered into a strategic alliance with SciCann Therapeutics Inc. ("SciCann") by executing a binding Memorandum of Understanding (the "MOU") dated May 28, 2018

Verona Pharma plc: 2017 Annual Report and Accounts and Notice of AGM

March 9, 2018, LONDON - Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for r...

Verona Pharma plc: Grant of Options and RSUs and PDMR Dealings

March 9, 2018, LONDON - Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for r...

LEO Pharma sells portfolio of 10 products for 260 million euros

Denmark’s LEO Pharma has sold a product portfolio of 10 products to Swedish firm Karo Pharma for 260…

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

#news #biotech Faron Pharma flummoxed as Traumakine fails in ARDS

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Faron Pharma flummoxed as Traumakine fails in ARDS .Shares in Finnish biotech Faron Pharma are in free fall this morning after a late-stage trial of its lead drug … Continue reading → Cet article #news #biotech Faron Pharma flummoxed as Traumakine fails in ARDS est...

EUSA Pharma: Strategies of a Speciality Company

In this exclusive interview, Fintan Walton talks to Bryan Morton, Founder and CEO of EUSA Pharma. Bryan begins by discussing the establishment of EUSA Pharma, and how its formation was motivated by the successful acquisition of Zeneus Pharma (also founded by Bryan), by Cephalon in 2005. Bryan talks about the three speciality pharma models employed by EUSA, the similiarities and differences between...

Big Pharma’s Opposition To Medical Marijuana: What’s Holding Them Back?

NewsDespite studies demonstrating the medical benefits of marijuana, there still are many parties that oppose its legalization. Big Pharma is playing a big role in that regard. The question is, why?

An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD.)

It's been an action-packed week with announcements of a number of FDA approvals, a couple of Big Pharma names failing in late-stage trials, and two acquisitions. Let's take a look at the pharma stocks and upcoming events to keep an ear out for in the coming week.

What have pharma companies learned from digital health mistakes?

A panel discussion at the Eye for Pharma conference in Philadelphia this week reflected how pharma companies such as GSK and Novartis are im


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks